Your browser doesn't support javascript.
loading
Association of MMP9 with adverse features of plaque progression and residual inflammatory risk in patients with chronic coronary syndrome (CCS).
Caselli, Chiara; Di Giorgi, Nicoletta; Ragusa, Rosetta; Lorenzoni, Valentina; Smit, Jeff; El Mahdiui, Mohammed; Buechel, Ronny R; Teresinska, Anna; Pizzi, Maria N; Roque, Albert; Poddighe, Rosa; Knuuti, Juhani; Schütte, Moritz; Parodi, Oberdan; Pelosi, Gualtiero; Scholte, Arthur; Rocchiccioli, Silvia; Neglia, Danilo.
Afiliación
  • Caselli C; Institute of Clinical Physiology CNR, Via G. Moruzzi 1, Pisa, Italy. Electronic address: chiara.caselli@ifc.cnr.it.
  • Di Giorgi N; Institute of Clinical Physiology CNR, Via G. Moruzzi 1, Pisa, Italy. Electronic address: digiorgi@ifc.cnr.it.
  • Ragusa R; Institute of Clinical Physiology CNR, Via G. Moruzzi 1, Pisa, Italy. Electronic address: rragusa@ifc.cnr.it.
  • Lorenzoni V; Sant'Anna School of Advanced Studies, Piazza Martiri della Libertà, 33, Pisa, Italy. Electronic address: v.lorenzoni@sssup.it.
  • Smit J; Department of Cardiology, Heart Lung Center, Leiden University Medical Centre, Albinusdreef 2, RC, Leiden, the Netherlands. Electronic address: j.m.smit@lumc.nl.
  • El Mahdiui M; Department of Cardiology, Heart Lung Center, Leiden University Medical Centre, Albinusdreef 2, RC, Leiden, the Netherlands. Electronic address: M.el_Mahdiui@lumc.nl.
  • Buechel RR; Department of Nuclear Medicine, Cardiac Imaging, University Hospital and University of Zurich, Switzerland. Electronic address: ronny.buechel@usz.ch.
  • Teresinska A; National Institute of Cardiology, Warsaw, Poland. Electronic address: ateresinska@ikard.pl.
  • Pizzi MN; Department of Cardiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Roque A; Department of Cardiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Poddighe R; ASL12 U.O.C, Cardiologia, Viareggio, Italy. Electronic address: rosa.poddighe@uslnordovest.toscana.it.
  • Knuuti J; PET Center, Turku University Hospital and University of Turku, Kiinamyllynkatu 4-8, Turku, Finland. Electronic address: juhani.knuuti@utu.fi.
  • Schütte M; Alacris Theranostics GmbH, Max-Planck-Straße 3, 12489 Berlin, Germany. Electronic address: m.schuette@alacris.de.
  • Parodi O; Fondazione Toscana G. Monasterio, Via G. Moruzzi 1, Pisa, Italy.
  • Pelosi G; Institute of Clinical Physiology CNR, Via G. Moruzzi 1, Pisa, Italy. Electronic address: pelosi@ifc.cnr.it.
  • Scholte A; Department of Cardiology, Heart Lung Center, Leiden University Medical Centre, Albinusdreef 2, RC, Leiden, the Netherlands. Electronic address: a.j.h.a.scholte@lumc.nl.
  • Rocchiccioli S; Institute of Clinical Physiology CNR, Via G. Moruzzi 1, Pisa, Italy. Electronic address: silvia.rocchiccioli@ifc.cnr.it.
  • Neglia D; Fondazione Toscana G. Monasterio, Via G. Moruzzi 1, Pisa, Italy. Electronic address: dneglia@ftgm.it.
Vascul Pharmacol ; 146: 107098, 2022 10.
Article en En | MEDLINE | ID: mdl-36100166
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de la Arteria Coronaria / Placa Aterosclerótica Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: Vascul Pharmacol Asunto de la revista: ANGIOLOGIA / FARMACOLOGIA Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de la Arteria Coronaria / Placa Aterosclerótica Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: Vascul Pharmacol Asunto de la revista: ANGIOLOGIA / FARMACOLOGIA Año: 2022 Tipo del documento: Article